Board of Directors

Anjen Chenn, M.D.-Ph.D. is a physician-scientist and Associate Professor of Pathology at the University of Illinois, Chicago.

Anjen received his A.B., summa cum laude in biochemical sciences at Harvard University and his M.D. and Ph.D. in neurosciences from Stanford University.  He completed his residency in clinical pathology at the Brigham and Women’s Hospital in Boston, Massachusetts and was Howard Hughes Medical Institute Physician Postdoctoral Fellow in the lab of Dr. Christopher Walsh at Beth Israel Deaconess Medical Center in Boston and an instructor at Harvard Medical School.  He then became Assistant Professor at Northwestern University Feinberg School of Medicine and ran a research lab studying developmental brain disorders and brain cancer and performed clinical work as director of molecular diagnostics at Northwestern Memorial Hospital in Chicago. Anjen’s research laboratory received funding from NIH (NINDS, NCI), Sontag Foundation for Brain Tumor Research, Searle Scholars Program, March of Dimes, Simons Foundation for Autism Research Initiative, and the V Foundation.  As an Associate Professor (with tenure) at University of Illinois, Chicago, he also served as director of clinical pathology at the University of Illinois Hospital in Chicago, where he established a new program for Personalized Diagnostics, also known as the Laboratory for Innovative Care and Research.  Anjen is Board-certified in Clinical Pathology and Molecular Genetic Pathology.  Anjen has been active in medical and graduate education since 1993, when he was a graduate student in the Medical Scientist Training Program at Stanford Medical School.  As a faculty member, Anjen developed online teaching tools for medical student, resident, and attending physician education at Harvard, Northwestern, and University of Illinois.  He mentored numerous students, technicians, and postdocs in his research laboratories, including 3 MD-PhD and 3 PhD students.  He has published 33 primary research articles, with articles featured on the cover of the journals Cell, Science, and Developmental Biology.

 

John Doux, M.D. is a practicing dermatologist and analyst at Palo Alto Investors.

John obtained a B.S. with distinction and an M.D. from Stanford University, where he was a Howard Hughes Medical Institute Fellow performing research in the laboratory of Dr. David Woodley. After an internship at Brigham and Women’s Hospital in Boston, he returned to Stanford to complete his residency training in dermatology. He also completed an M.B.A. at the Wharton School of Business where he was a Palmer Scholar.  Since 2004 he has been an analyst at Palo Alto Investors, an investment fund specializing in healthcare with $1B in assets under management, where he specializes in the healthcare sector.  He also serves as a Director at Brickell Biotech, Inc.  John is board certified in dermatology.  John has an extensive background teaching students and resident physicians and fellows at Stanford Medical School and Harvard Medical School.

 

Jonathan I. Lieber is Chief Financial Officer at Histogenics Corporation.

Jon received a B.S. in Business Administration and Finance from Boston University and an M.B.A. in finance from New York University Stern School of Business.  He was an investment banker for 10 years where he originated and executed on numerous corporate financings and merger and acquisition transactions at SG Cowen and Salomon Brothers Inc.  Jon became Vice President of Finance of Altus Pharmaceuticals Inc. in 2002 and also served as its Treasurer from September 2005 to March 27, 2009 where he led all public and private capital raising activities at the company, including its $110 million initial public offering and a subsequent $90 million follow-on offering.  He was Chief Financial Officer of Xcellerex, Inc. from 2009 to 2012, then served as Chief Financial Officer and Treasurer of Repligen Corporation from September 21, 2012 to August 23, 2013.  Jon was the Chief Financial Officer and Senior Vice President at Metamark Genetics, Inc. from January 29, 2014 to July 2015.  Jon also serves on the Boards of several Wheatley portfolio companies.  Jon specializes in the services, software, and communications sectors. He has more than 20 years of executive management experience at emerging growth life sciences companies and in investment banking companies including, Repligen Corporation, Xcellerex (acquired by GE Healthcare), and Altus Pharmaceuticals.  Mr. Lieber is involved in healthcare financings totaling over $3 billion in common stock and over $500 million in initial public offerings.


Scientific and Technical Advisors

Maarten C. Bosland, D.V.Sc., Ph. D. is Professor of Pathology at University of Illinois, Chicago (UIC).

Maarten graduated from the University of Utrecht (The Netherlands) in 1978 with a Doctoral Degree in Veterinary Science (DVSc) and received in 1989 a Doctorate Degree (PhD) in Experimental Pathology from the same University. He is a Board Certified in Laboratory Animal Pathology and Laboratory Animal Science (in The Netherlands). He was Research Scientist-Toxicologic Pathologist at TNO, Zeist, The Netherlands from 1978-1988. From 1985-2006, he has been on the Faculty of the Department of Environmental Medicine of New York University (NYU) School of Medicine, since 2000 as Professor of Environmental Medicine and Urology. Since 2006, he has been Professor and Director of Graduate Studies in the Department of Pathology at the University of Illinois at Chicago (UIC) College of Medicine. He has published over 155 articles and book chapters about his research, which has focused on prostate cancer, chemoprevention of cancer, and hormonal carcinogenesis. His current research interests include mechanisms of hormonal prostate carcinogenesis, particularly the role of estrogens and androgens, prostate cancer chemoprevention, and preclinical research and human clinical trials of chemoprevention by natural substances, in particular dietary antioxidants, soy, and soy isoflavones. He has directed a satellite animal facility and a histopathology facility at NYU. He has served on the Animal Care Committees and on Graduate Student Steering Committees at NYU and UIC. He has also served on expert panel committees of the WHO (for the International Agency for Research on Cancer) and the US National Academy of Science. He is currently also involved in capacity building in pathology in Ghana, teaching medical students in Ghana, and collaborative research on prostate cancer and anticancer properties of West African medicinal plants with investigators at universities in Nigeria and Ghana.  In 2014, Maarten established a collaborative program between UIC and the Korle-Bu Teaching Hospital (KBTH) in Accra and Komfo Anyoke Teaching Hospital (KATH) in Kumasi in Ghana to assist in the pathology residency training programs accredited by the Ghana College of Physicians and Surgeons.  Ghana, a country of 26 million people, has fewer than 15 pathologists.  Maarten’s program utilizes cutting-edge telepathology and teleconferencing to provide remote consultation and case conference review in resident training sessions with UIC pathologists.

 

Ian Gilman is a Freelance Creator and Digital Renaissance Man

Ian got his first programming job at the age of seventeen creating the computer game Ishido for Accolade. He because Lead Software Engineer for Buena Vista Software, Inc., 1990-1991, developing Heaven & Earth and Seize the Day. Ian then created the graphics and animations for the arcade game Maelstrom at Ambrosia Software, Inc., 1991. From 1995-1999, Ian worked with MetaCreations (originally HSC Software, now Viewpoint) and developing Internet-based multi-player games, most notably MetaSquares, and became involved with virtual community work, including SoapTalk and BryceTalk.  He then became Senior Software Engineer and Founding Member of Byteburg, a future design thinktank at Applied Innovations, A.G., in 2000.  After work with Live 365 (2001), he became Chief Architect at Quantum Mana from 2003-2005.  He was Senior Developer at Seadragon Software developing the Seadragon data navigation system.  At Microsoft Live Labs from 2006-2010, Ian was Development Lead for SeadragonPhotosynth (a 3D photo viewer), Snapdragon (an immersive photo explorer), and Infinite Canvas (elegant comic viewer).  Ian was Feature Lead Developer for Mozilla Corporation, 2010-2011, developing Firefox Panorama, for next-generation web navigation. Ian then worked as Mobile Web Developer for Applied Information Sciences, 2011-2012 , developing tablet magazine viewers for Vogue Archive, Rolling Stone Archive, and, iPlayboy and then as a Web/APIdeveloper, with Rdio Developers, developer support site Rdio JavaScript API, music streaming API Rdio Inc., 2012-2013.  Ian has expertise in Dynamic web applications, User interface and graphic design, Community design and management, Team management. Game design, Film production, editing and special effects and technologies including JavaScript, HTML5, CSS3, jQuery, Underscore, Backbone, Node, Grunt, OpenSeadragon, and Rdio API.